Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Moderna, Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $94.9 Billion
- Q3 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Moderna, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 16,939 shares of MRNA stock, worth $670,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,939
Previous 77,010
78.0%
Holding current value
$670,615
Previous $9.14 Million
87.62%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.68 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$667 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$286 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...